Allegro Gets Another $5.4M

7/7/11

Maynard, MA-based Allegro Diagnostics said today that it has plumped up its Series A financing by another $5.4 million. The money comes from existing investors Kodiak Venture Partners and Catalyst Health Ventures. Allegro is developing a diagnostic platform for lung cancer that uses gene expression of normal epithelial cells in the respiratory tract to detect early signs of the disease.

By posting a comment, you agree to our terms and conditions.